tiprankstipranks
Gyre Therapeutics (GYRE)
NASDAQ:GYRE
US Market

Gyre Therapeutics (GYRE) Income Statement

Compare
801 Followers

Gyre Therapeutics Income Statement

Last quarter (Q3 2024), Gyre Therapeutics's total revenue was $25.49M, a decrease of -17.07% from the same quarter last year. In Q3, Gyre Therapeutics's net income was $5.00M. See Gyre Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 113.45M$ 794.00K$ 7.34M$ 20.95M$ 0.00
Gross Profit
$ 108.81M$ -4.00K$ -42.00K$ 11.79M$ -43.86M
Operating Expenses
$ 176.04M$ 30.40M$ 87.85M$ 69.16M$ 57.28M
Depreciation and Amortization
$ 1.11M$ 1.13M$ 290.00K$ 138.00K$ 146.00K
EBITDA
$ 20.33M$ 10.33M$ -87.60M$ -57.37M$ -57.28M
Operating Income
$ -67.23M$ -8.61M$ -87.89M$ -57.37M$ -57.28M
Other Income/Expenses
$ -9.73M$ 209.00K$ -39.00K$ 1.13M$ 2.10M
Pretax Income
$ -76.97M$ -7.89M$ -87.93M$ -56.24M$ -55.18M
Net Income
$ -92.93M$ 2.30M$ -87.93M$ -55.54M$ -52.89M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.41$ 0.04$ -2.87$ -2.90$ -4.41
Diluted EPS
$ -1.41$ 0.03$ -2.87$ -2.90$ -4.41
Weighted Average Shares Outstanding
65.83M 76.74M 30.64M 19.18M 12.00M
Weighted Average Shares Outstanding (Diluted)
65.83M 75.69M 30.64M 19.18M 12.00M
Currency in USD

Gyre Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis